The FDA has approved a new option for the treatment of HIV-1 in adults as a replacement for current antiretroviral regimens in patients who are virologically suppressed and with no history of treatment...
The FDA has approved a new option for HIV-1 pre-exposure prophylaxis to reduce HIV-1 infection risk from sex, excluding in those who have receptive vaginal sex.
The US Food and Drug Administration has approved the smallest integrase strand transfer inhibitor-based triple-therapy single tablet regimen for adults with HIV-1.
After 2 clinical trials demonstrated its safety and efficacy, the US Food and Drug Administration approved the first complete HIV treatment regimen containing only 2 drugs.